A Medium-Chain Fatty Acid, Capric Acid, Inhibits RANKL-Induced Osteoclast Differentiation via the Suppression of NF-Kappa B Signaling and Blocks Cytoskeletal Organization and Survival in Mature Osteoclasts

다국어 초록 (Multilingual Abstract)

Fatty acids, important components of a normal diet, have been reported to play a role in bone metabolism. Osteoclasts are bone-resorbing cells that are responsible for many bone-destructive diseases such as osteoporosis. In this study, we investigated the impact of a medium-chain fatty acid, capric acid, on the osteoclast differentiation, function, and survival induced by receptor activator of NF-κB ligand (RANKL) and macrophage colony-stimulating factor (MCSF).
Capric acid inhibited RANKL-mediated osteoclastogenesis in bone marrow-derived macrophages and suppressed RANKL-induced IκBα phosphorylation, p65 nuclear translocation, and NF-κB transcriptional activity. Capric acid further blocked the RANKL-stimulated activation of ERK without affecting JNK or p38. The induction of NFATc1 in response to RANKL was also attenuated by capric acid.
In addition, capric acid abrogated M-CSF and RANKLmediated cytoskeleton reorganization, which is crucial for the efficient bone resorption of osteoclasts. Capric acid also increased apoptosis in mature osteoclasts through the induction of Bim expression and the suppression of ERK activation by M-CSF. Together, our results reveal that capric acid has inhibitory effects on osteoclast development.
We therefore suggest that capric acid may have potential therapeutic implications for the treatment of bone resorption- associated disorders.

참고문헌 (Reference)

1 김현주, "The tyrosine kinase inhibitor GNF-2 suppresses osteoclast formation and activity" FEDERATION AMER SOC EXP BIOL 95 (95): 337-345, 2014

2 Novack, D. V., "The osteoclast : friend or foe?" 3 : 457-484, 2008

3 Asagiri, M., "The molecular understanding of osteoclast differentiation" 40 : 251-264, 2007

4 Vaananen, H. K., "The cell biology of osteoclast function" 113 (113): 377-381, 2000

5 Kim, H. J., "Suppression of osteoclastogenesis by N, N-dimethyl-D-erythro-sphingosine : a sphingosine kinase inhibition-independent action" 72 : 418-428, 2007

6 Franzoso, G., "Requirement for NF-kappaB in osteoclast and B-cell development" 11 : 3482-3496, 1997

7 Akiyama, T., "Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim" 22 : 6653-6664, 2003

8 Iotsova, V., "Osteopetrosis in mice lacking NF-kappaB1 and NFkappaB2" 3 : 1285-1289, 1997

9 Teitelbaum, S. L., "Osteoclasts : what do they do and how do they do it?" 170 : 427-435, 2007

10 Boyle, W. J., "Osteoclast differentiation and activation" 423 : 337-342, 2003

11 Nakashima, T., "New regulation mechanisms of osteoclast differentiation" 1240 : E13-E18, 2011

12 Cornish, J., "Modulation of osteoclastogenesis by fatty acids" 149 : 5688-5695, 2008

13 McHugh, K. P., "Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts" 105 : 433-440, 2000

14 김현주, "Inhibitory effects of obovatol on osteoclast differentiation and bone resorption" ELSEVIER SCIENCE BV 723 : 473-480, 2014

15 Faccio, R., "High dose M-CSF partially rescues the Dap12-/-osteoclast phenotype" 90 : 871-883, 2003

16 김현주, "Glucocorticoids suppress bone formation via the osteoclast" AMER SOC CLINICAL INVESTIGATION INC 116 (116): 2152-2160, 2006

17 He, L., "Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NFkappaB, NFATc1 and c-Fos" 50 : 1207-1213, 2012

18 Teitelbaum, S. L., "Genetic regulation of osteoclast development and function" 4 : 638-649, 2003

19 김현주, "Early growth response 2 negatively modulates osteoclast differentiation through upregulation of Id helix-loop-helix proteins" ELSEVIER SCIENCE INC 51 (51): 643-650, 2012

20 Rahman, M. M., "Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264. 7 cells than eicosapentaenoic acid" 214 : 201-209, 2008

21 Sun, D., "Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice" 18 : 1206-1216, 2003

22 Park, E. J., "Capric acid inhibits NO production and STAT3 activation during LPS-induced osteoclastogenesis" 6 : e27739-, 2011

23 Hong, J. M., "Calpain-6, a target molecule of glucocorticoids, regulates osteoclastic bone resorption via cytoskeletal organization and microtubule acetylation" 26 : 657-665, 2011

24 T. John Martin, "Bone Biology and Anabolic Therapies for Bone: Current Status and Future Prospects" 대한골대사학회 21 (21): 8-20, 2014

25 Asagiri, M., "Autoamplification of NFATc1 expression determines its essential role in bone homeostasis" 202 : 1261-1269, 2005